speb/financial-data huggingface dataset:
PHGE balance_sheet (quarterly, 2025-09-30) — Other Receivables: 280000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Payables: 2873000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3930000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 18617000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 18617000.00
PHGE cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 0.00
PHGE balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 386000.00
PHGE income_statement (quarterly, 2025-09-30) — Pretax Income: -9163000.00
PHGE cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
PHGE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Receivables: 280000.00
PHGE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1241000.00
PHGE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
PHGE income_statement (quarterly, 2025-09-30) — Research And Development: 6122000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 985000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -203559000.00
PHGE cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
PHGE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2414000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Share Issued: 1410577.00
PHGE income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
PHGE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 438000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 10486000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -20181000.00
PHGE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -153300.00
PHGE income_statement (quarterly, 2025-09-30) — Tax Provision: 3000.00
PHGE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
PHGE balance_sheet (quarterly, 2025-09-30) — Total Assets: 26168000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 10486000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Total Debt: 6583000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 10486000.00
PHGE income_statement (quarterly, 2025-09-30) — Total Expenses: 8536000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 15682000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 17306000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 10456000.00
PHGE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -8536000.00
PHGE income_statement (quarterly, 2025-09-30) — Total Unusual Items: -730000.00
PHGE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -730000.00
PHGE balance_sheet (quarterly, 2025-09-30) — Working Capital: 3636000.00
PHGE income_statement (annual, 2025-12-31) — +Operating Expense: 30920000.00
PHGE income_statement (quarterly, 2025-12-31) — +Operating Expense: 7195000.00
PHGE income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
PHGE income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Accounts Payable: 3120000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3120000.00
PHGE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -5432000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -5432000.00
PHGE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 196970000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 196970000.00
PHGE cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 13495000.00
PHGE cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 13495000.00
PHGE balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 157000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 157000.00
PHGE income_statement (annual, 2025-12-31) — Average Dilution Earnings: 0.00
PHGE income_statement (quarterly, 2025-12-31) — Average Dilution Earnings: 0.00
PHGE income_statement (annual, 2025-12-31) — Basic Average Shares: 1631037.00
PHGE income_statement (annual, 2025-12-31) — Basic EPS: -22.19
PHGE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 17975000.00
PHGE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 8069000.00
PHGE cash_flow (annual, 2025-12-31) — Capital Expenditure: -2000.00
PHGE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1436000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1436000.00
PHGE balance_sheet (annual, 2025-12-31) — Capital Stock: 18624000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 18624000.00
PHGE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 4360000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 4360000.00
PHGE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4360000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4360000.00
PHGE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 13189000.00
PHGE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1251000.00
PHGE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 108000.00
PHGE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 1000.00
PHGE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -26390000.00
PHGE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -4386000.00
PHGE cash_flow (annual, 2025-12-31) — Change In Account Payable: 1238000.00
PHGE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1612000.00
PHGE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 2243000.00
PHGE cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 491000.00
PHGE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -74000.00
PHGE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -119000.00
PHGE cash_flow (annual, 2025-12-31) — Change In Payable: -2192000.00
PHGE cash_flow (quarterly, 2025-12-31) — Change In Payable: 1015000.00
PHGE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -2192000.00
PHGE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1015000.00
PHGE cash_flow (annual, 2025-12-31) — Change In Working Capital: -23000.00
PHGE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1387000.00
PHGE cash_flow (annual, 2025-12-31) — Changes In Cash: -13093000.00
PHGE cash_flow (quarterly, 2025-12-31) — Changes In Cash: -3134000.00
PHGE balance_sheet (annual, 2025-12-31) — Common Stock: 7000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Common Stock: 7000.00
PHGE balance_sheet (annual, 2025-12-31) — Common Stock Equity: -19919000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -19919000.00
PHGE cash_flow (annual, 2025-12-31) — Common Stock Issuance: 8774000.00
PHGE cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1251000.00
PHGE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 720000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 720000.00
PHGE balance_sheet (annual, 2025-12-31) — Current Assets: 5575000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Current Assets: 5575000.00
PHGE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1436000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1436000.00
PHGE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1436000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1436000.00
PHGE balance_sheet (annual, 2025-12-31) — Current Liabilities: 6379000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 6379000.00
PHGE cash_flow (annual, 2025-12-31) — Depreciation: 2922000.00
PHGE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2922000.00
PHGE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1153000.00
PHGE income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 658000.00
PHGE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2922000.00
PHGE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1153000.00
PHGE income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 658000.00
PHGE income_statement (annual, 2025-12-31) — Depreciation Income Statement: 658000.00
PHGE balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 706000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 706000.00
PHGE income_statement (annual, 2025-12-31) — Diluted Average Shares: 1631037.00
PHGE income_statement (annual, 2025-12-31) — Diluted EPS: -22.19
PHGE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -36199000.00
PHGE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -13337000.00
PHGE income_statement (annual, 2025-12-31) — EBIT: -36172000.00
PHGE income_statement (quarterly, 2025-12-31) — EBIT: -14077000.00
PHGE income_statement (annual, 2025-12-31) — EBITDA: -33250000.00
PHGE income_statement (quarterly, 2025-12-31) — EBITDA: -12924000.00
PHGE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 73000.00
PHGE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 20000.00
PHGE cash_flow (annual, 2025-12-31) — End Cash Position: 4955000.00
PHGE cash_flow (quarterly, 2025-12-31) — End Cash Position: 4955000.00
PHGE cash_flow (annual, 2025-12-31) — Financing Cash Flow: 13189000.00
PHGE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 1251000.00
PHGE cash_flow (annual, 2025-12-31) — Free Cash Flow: -26392000.00
PHGE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4386000.00
PHGE cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -6111000.00
PHGE cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -4429000.00
PHGE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 205000.00
PHGE cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 40000.00
PHGE income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 5891000.00
PHGE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 4209000.00
PHGE income_statement (annual, 2025-12-31) — General And Administrative Expense: 8970000.00
PHGE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1631000.00
PHGE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 208000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 208000.00
PHGE balance_sheet (annual, 2025-12-31) — Gross PPE: 0.00
PHGE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 0.00
PHGE income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 13495000.00
PHGE income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 13495000.00
PHGE cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 7000.00
PHGE cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1000.00
PHGE income_statement (annual, 2025-12-31) — Insurance And Claims: 1191000.00
PHGE income_statement (annual, 2025-12-31) — Interest Expense: 20000.00
PHGE income_statement (quarterly, 2025-12-31) — Interest Expense: -741000.00
PHGE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 20000.00
PHGE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: -741000.00
PHGE income_statement (annual, 2025-12-31) — Interest Income: 460000.00
PHGE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 460000.00
PHGE cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 20000.00
PHGE cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 5000.00
PHGE balance_sheet (annual, 2025-12-31) — Invested Capital: -19919000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Invested Capital: -19919000.00
PHGE cash_flow (annual, 2025-12-31) — Investing Cash Flow: 108000.00
PHGE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 1000.00
PHGE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 8774000.00
PHGE cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1251000.00
PHGE balance_sheet (annual, 2025-12-31) — Leases: 0.00
PHGE balance_sheet (quarterly, 2025-12-31) — Leases: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
PHGE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
PHGE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
PHGE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
PHGE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 561000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 561000.00
PHGE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
PHGE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 8774000.00
PHGE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1251000.00
PHGE income_statement (annual, 2025-12-31) — Net Income: -36199000.00
PHGE income_statement (quarterly, 2025-12-31) — Net Income: -13337000.00
PHGE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -36199000.00
PHGE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -13337000.00
PHGE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -36199000.00
PHGE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -13337000.00
PHGE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -36199000.00
PHGE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -13337000.00
PHGE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -36199000.00
PHGE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -13337000.00
PHGE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -36199000.00
PHGE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -13337000.00
PHGE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -36199000.00
PHGE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -13337000.00
PHGE income_statement (annual, 2025-12-31) — Net Interest Income: -524000.00
PHGE income_statement (quarterly, 2025-12-31) — Net Interest Income: 237000.00
PHGE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
PHGE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
PHGE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
PHGE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
PHGE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -524000.00
PHGE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 237000.00
PHGE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -118000.00
PHGE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Net PPE: 0.00
PHGE balance_sheet (quarterly, 2025-12-31) — Net PPE: 0.00
PHGE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 108000.00
PHGE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 1000.00
PHGE cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
PHGE cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -1510000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -1510000.00
PHGE income_statement (annual, 2025-12-31) — Normalized EBITDA: -28595000.00
PHGE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -6587000.00
PHGE income_statement (annual, 2025-12-31) — Normalized Income: -32521550.00
PHGE income_statement (quarterly, 2025-12-31) — Normalized Income: -8330770.00
PHGE cash_flow (annual, 2025-12-31) — Operating Cash Flow: -26390000.00
PHGE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -4386000.00
PHGE cash_flow (annual, 2025-12-31) — Operating Gains Losses: -5906000.00
PHGE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -4389000.00
PHGE income_statement (annual, 2025-12-31) — Operating Income: -30920000.00
PHGE income_statement (quarterly, 2025-12-31) — Operating Income: -7195000.00
PHGE income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
PHGE income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1593703.00
PHGE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1593703.00
PHGE balance_sheet (annual, 2025-12-31) — Other Current Assets: 122000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 122000.00
PHGE income_statement (annual, 2025-12-31) — Other Gand A: 3310000.00
PHGE income_statement (quarterly, 2025-12-31) — Other Gand A: -4029000.00
PHGE income_statement (annual, 2025-12-31) — Other Income Expense: -4748000.00
PHGE income_statement (quarterly, 2025-12-31) — Other Income Expense: -6378000.00
PHGE balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 208000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 208000.00
PHGE cash_flow (annual, 2025-12-31) — Other Non Cash Items: -2770000.00
PHGE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -2993000.00
PHGE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: -157000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: -157000.00
PHGE income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -93000.00
PHGE income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -41000.00
PHGE balance_sheet (annual, 2025-12-31) — Other Payable: 1103000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Other Payable: 1103000.00
PHGE balance_sheet (annual, 2025-12-31) — Other Properties: 5028000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Other Properties: 5028000.00
PHGE income_statement (annual, 2025-12-31) — Other Special Charges: -2949000.00
PHGE balance_sheet (annual, 2025-12-31) — Payables: 4223000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Payables: 4223000.00
PHGE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 4943000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 4943000.00
PHGE balance_sheet (annual, 2025-12-31) — Preferred Stock: 18617000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 18617000.00
PHGE balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 18617000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 18617000.00
PHGE cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 0.00
PHGE cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Prepaid Assets: 341000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 341000.00
PHGE income_statement (annual, 2025-12-31) — Pretax Income: -36192000.00
PHGE income_statement (quarterly, 2025-12-31) — Pretax Income: -13336000.00
PHGE cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 4533000.00
PHGE cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Properties: 0.00
PHGE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PHGE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2000.00
PHGE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Receivables: 0.00
PHGE balance_sheet (quarterly, 2025-12-31) — Receivables: 0.00
PHGE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2922000.00
PHGE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1153000.00
PHGE income_statement (annual, 2025-12-31) — Rent And Landing Fees: 602000.00
PHGE income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 602000.00
PHGE cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
PHGE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
PHGE income_statement (annual, 2025-12-31) — Research And Development: 21292000.00
PHGE income_statement (quarterly, 2025-12-31) — Research And Development: 4906000.00
PHGE balance_sheet (annual, 2025-12-31) — Restricted Cash: 595000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 595000.00
PHGE income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
PHGE balance_sheet (annual, 2025-12-31) — Retained Earnings: -216896000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -216896000.00
PHGE income_statement (annual, 2025-12-31) — Salaries And Wages: 3867000.00
PHGE cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
PHGE cash_flow (annual, 2025-12-31) — Sale Of PPE: 110000.00
PHGE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 1000.00
PHGE income_statement (annual, 2025-12-31) — Selling General And Administration: 8970000.00
PHGE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1631000.00
PHGE balance_sheet (annual, 2025-12-31) — Share Issued: 1593703.00
PHGE balance_sheet (quarterly, 2025-12-31) — Share Issued: 1593703.00
PHGE income_statement (annual, 2025-12-31) — Special Income Charges: -10546000.00
PHGE income_statement (quarterly, 2025-12-31) — Special Income Charges: -10546000.00
PHGE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2091000.00
PHGE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 298000.00
PHGE balance_sheet (annual, 2025-12-31) — Stockholders Equity: -1302000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -1302000.00
PHGE balance_sheet (annual, 2025-12-31) — Tangible Book Value: -20127000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -20127000.00
PHGE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -977550.00
PHGE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -1330770.00
PHGE income_statement (annual, 2025-12-31) — Tax Provision: 7000.00
PHGE income_statement (quarterly, 2025-12-31) — Tax Provision: 1000.00
PHGE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
PHGE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
PHGE balance_sheet (annual, 2025-12-31) — Total Assets: 5783000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Total Assets: 5783000.00
PHGE balance_sheet (annual, 2025-12-31) — Total Capitalization: -1302000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -1302000.00
PHGE balance_sheet (annual, 2025-12-31) — Total Debt: 1436000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Total Debt: 1436000.00
PHGE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -1302000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -1302000.00
PHGE income_statement (annual, 2025-12-31) — Total Expenses: 30920000.00
PHGE income_statement (quarterly, 2025-12-31) — Total Expenses: 7195000.00
PHGE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 7085000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 7085000.00
PHGE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 208000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 208000.00
PHGE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 706000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 706000.00
PHGE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -41466000.00
PHGE income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -17741000.00
PHGE income_statement (annual, 2025-12-31) — Total Other Finance Cost: 964000.00
PHGE income_statement (annual, 2025-12-31) — Total Unusual Items: -4655000.00
PHGE income_statement (quarterly, 2025-12-31) — Total Unusual Items: -6337000.00
PHGE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -4655000.00
PHGE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -6337000.00
PHGE balance_sheet (annual, 2025-12-31) — Working Capital: -804000.00
PHGE balance_sheet (quarterly, 2025-12-31) — Working Capital: -804000.00
PHGE income_statement (quarterly, 2026-03-31) — +Operating Expense: 1296000.00
PHGE income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
PHGE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 720000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 219831000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
PHGE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 2603807.00
PHGE income_statement (quarterly, 2026-03-31) — Basic EPS: -7.38
PHGE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 4955000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 0.00
PHGE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 18624000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1168000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1168000.00
PHGE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 2623000.00
PHGE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -996000.00
PHGE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -5414000.00
PHGE cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 274000.00
PHGE cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -1412000.00
PHGE cash_flow (quarterly, 2026-03-31) — Change In Payable: -927000.00
PHGE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -927000.00
PHGE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2339000.00
PHGE cash_flow (quarterly, 2026-03-31) — Changes In Cash: -3787000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Common Stock: 7000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -19498000.00
PHGE cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
PHGE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 82000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Current Assets: 3043000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 0.00
PHGE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2447000.00
PHGE cash_flow (quarterly, 2026-03-31) — Depreciation: 0.00
PHGE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 0.00
PHGE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 0.00
PHGE balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 1685000.00
PHGE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 2603807.00
PHGE income_statement (quarterly, 2026-03-31) — Diluted EPS: -7.38
PHGE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -19225000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 1254000.00
PHGE income_statement (quarterly, 2026-03-31) — EBIT: -18948000.00
PHGE income_statement (quarterly, 2026-03-31) — EBITDA: -18948000.00
PHGE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 0.00
PHGE cash_flow (quarterly, 2026-03-31) — End Cash Position: 1168000.00
PHGE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 2623000.00
PHGE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -5414000.00
PHGE cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 14242000.00
PHGE cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -1860000.00
PHGE cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
PHGE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Business: 1860000.00
PHGE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -14056000.00
PHGE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1611000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 208000.00
PHGE cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
PHGE income_statement (quarterly, 2026-03-31) — Interest Expense: 192000.00
PHGE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 192000.00
PHGE cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
PHGE balance_sheet (quarterly, 2026-03-31) — Invested Capital: -19498000.00
PHGE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -996000.00
PHGE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 2623000.00
PHGE cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -996000.00
PHGE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
PHGE income_statement (quarterly, 2026-03-31) — Net Income: -19140000.00
PHGE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -19225000.00
PHGE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -19140000.00
PHGE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -19140000.00
PHGE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -19140000.00
PHGE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -19140000.00
PHGE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -19140000.00
PHGE income_statement (quarterly, 2026-03-31) — Net Interest Income: -569000.00
PHGE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -569000.00
PHGE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
PHGE cash_flow (quarterly, 2026-03-31) — Net Preferred Stock Issuance: 2623000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -1089000.00
PHGE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -1526000.00
PHGE income_statement (quarterly, 2026-03-31) — Normalized Income: -1718000.00
PHGE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -5414000.00
PHGE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 12382000.00
PHGE income_statement (quarterly, 2026-03-31) — Operating Income: -1296000.00
PHGE income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
PHGE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 6543703.00
PHGE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 74000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: -82000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -3300000.00
PHGE income_statement (quarterly, 2026-03-31) — Other Gand A: 1611000.00
PHGE income_statement (quarterly, 2026-03-31) — Other Income Expense: -17275000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 208000.00
PHGE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 5611000.00
PHGE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 147000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Other Payable: 473000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Payables: 2447000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 2529000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 18617000.00
PHGE income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 85000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 18617000.00
PHGE cash_flow (quarterly, 2026-03-31) — Preferred Stock Issuance: 2623000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1801000.00
PHGE income_statement (quarterly, 2026-03-31) — Pretax Income: -19140000.00
PHGE cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
PHGE cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -996000.00
PHGE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 0.00
PHGE income_statement (quarterly, 2026-03-31) — Research And Development: -315000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 0.00
PHGE income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 5226000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -236036000.00
PHGE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
PHGE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1611000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Share Issued: 6543703.00
PHGE income_statement (quarterly, 2026-03-31) — Special Income Charges: -3366000.00
PHGE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: -1928000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -881000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -19706000.00
PHGE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
PHGE income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
PHGE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
PHGE balance_sheet (quarterly, 2026-03-31) — Total Assets: 3251000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -881000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Total Debt: 0.00
PHGE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -881000.00
PHGE income_statement (quarterly, 2026-03-31) — Total Expenses: 1296000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4132000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 208000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1685000.00
PHGE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -1296000.00
PHGE income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 377000.00
PHGE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -17422000.00
PHGE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -17422000.00
PHGE balance_sheet (quarterly, 2026-03-31) — Working Capital: 596000.00
PHI cash_flow (annual, 2021-12-31) — Dividends Received Cfi: 0.00
PHI cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -826000000.00
PHI income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 941000000.00
PHI balance_sheet (annual, 2021-12-31) — Held To Maturity Securities: 400000000.00
PHI cash_flow (annual, 2021-12-31) — Net Investment Properties Purchase And Sale: 0.00
PHI cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 170000000.00
PHI balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 94777000000.00
PHI balance_sheet (annual, 2021-12-31) — Other Payable: 10405000000.00
PHI income_statement (annual, 2021-12-31) — Other Special Charges: -3966000000.00
PHI balance_sheet (annual, 2021-12-31) — Prepaid Assets: 12707000000.00
PHI cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 0.00
PHI cash_flow (annual, 2021-12-31) — Sale Of Investment Properties: 0.00
PHI income_statement (annual, 2022-12-31) — +Operating Expense: 183107000000.00
PHI income_statement (annual, 2022-12-31) — +Total Revenue: 204362000000.00
PHI balance_sheet (annual, 2022-12-31) — Accounts Payable: 100865000000.00
PHI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 26255000000.00
PHI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -558011000000.00
PHI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 130312000000.00
PHI balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -13661000000.00
PHI income_statement (annual, 2022-12-31) — Amortization: 228000000.00
PHI cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 228000000.00
PHI cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 228000000.00
PHI income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 228000000.00
PHI cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 6157000000.00
PHI balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 8771000000.00
PHI balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 4085000000.00
PHI income_statement (annual, 2022-12-31) — Basic Average Shares: 217260671.00
PHI income_statement (annual, 2022-12-31) — Basic EPS: 48.26
PHI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 23907000000.00
PHI balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 28208000000.00
PHI cash_flow (annual, 2022-12-31) — Capital Expenditure: -95551000000.00
PHI cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -1748000000.00
PHI balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 42435000000.00
PHI balance_sheet (annual, 2022-12-31) — Capital Stock: 1603000000.00
PHI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 25211000000.00
PHI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 25800000000.00
PHI cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -25235000000.00
PHI balance_sheet (annual, 2022-12-31) — Cash Equivalents: 8678000000.00
PHI balance_sheet (annual, 2022-12-31) — Cash Financial: 16533000000.00
PHI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -42304000000.00
PHI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -33006000000.00
PHI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 76200000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Account Payable: -18306000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -507000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Inventory: 410000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 208000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -68000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -6803000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Payable: -18306000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -18813000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 12218000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Receivables: -8575000000.00
PHI cash_flow (annual, 2022-12-31) — Change In Working Capital: -21423000000.00
PHI cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -8366000000.00
PHI cash_flow (annual, 2022-12-31) — Changes In Cash: 890000000.00
PHI balance_sheet (annual, 2022-12-31) — Common Stock: 1093000000.00
PHI balance_sheet (annual, 2022-12-31) — Common Stock Equity: 108217000000.00
PHI balance_sheet (annual, 2022-12-31) — Construction In Progress: 55427000000.00
PHI income_statement (annual, 2022-12-31) — Cost Of Revenue: 20276000000.00
PHI balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 65599000000.00
PHI balance_sheet (annual, 2022-12-31) — Current Assets: 81329000000.00
PHI balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 10477000000.00
PHI balance_sheet (annual, 2022-12-31) — Current Debt: 32292000000.00
PHI balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 42769000000.00
PHI balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 9499000000.00
PHI balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 9499000000.00
PHI balance_sheet (annual, 2022-12-31) — Current Liabilities: 247002000000.00
PHI cash_flow (annual, 2022-12-31) — Depreciation: 98714000000.00
PHI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 98942000000.00
PHI income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 98859000000.00
PHI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 98942000000.00
PHI income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 98859000000.00
PHI income_statement (annual, 2022-12-31) — Depreciation Income Statement: 98631000000.00
PHI balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 190000000.00
PHI income_statement (annual, 2022-12-31) — Diluted Average Shares: 217260671.00
PHI income_statement (annual, 2022-12-31) — Diluted EPS: 48.26
PHI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 10426000000.00
PHI balance_sheet (annual, 2022-12-31) — Dividends Payable: 1821000000.00
PHI cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 0.00
PHI balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 270000000.00
PHI income_statement (annual, 2022-12-31) — EBIT: 25576000000.00
PHI income_statement (annual, 2022-12-31) — EBITDA: 124518000000.00
PHI income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -3304000000.00
PHI cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 3304000000.00
PHI cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 414000000.00
PHI balance_sheet (annual, 2022-12-31) — Employee Benefits: 1745000000.00
PHI cash_flow (annual, 2022-12-31) — End Cash Position: 25211000000.00
PHI balance_sheet (annual, 2022-12-31) — Financial Assets: 81000000.00
PHI balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 432000000.00
PHI cash_flow (annual, 2022-12-31) — Financing Cash Flow: -42304000000.00
PHI balance_sheet (annual, 2022-12-31) — Finished Goods: 2110000000.00
PHI cash_flow (annual, 2022-12-31) — Free Cash Flow: -19351000000.00
PHI cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -2322000000.00
PHI cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -660000000.00
PHI cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -26000000000.00
PHI income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 660000000.00
PHI income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 26000000000.00
PHI income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -2365000000.00
PHI balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -35482000000.00
PHI income_statement (annual, 2022-12-31) — General And Administrative Expense: 44723000000.00
PHI balance_sheet (annual, 2022-12-31) — Goodwill: 62941000000.00
PHI balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 64549000000.00
PHI balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 39916000000.00
PHI balance_sheet (annual, 2022-12-31) — Gross PPE: 879619000000.00
PHI income_statement (annual, 2022-12-31) — Gross Profit: 184086000000.00
PHI balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 0.00
PHI balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 596000000.00
PHI income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 282000000.00
PHI balance_sheet (annual, 2022-12-31) — Income Tax Payable: 982000000.00
PHI income_statement (annual, 2022-12-31) — Insurance And Claims: 1576000000.00
PHI income_statement (annual, 2022-12-31) — Interest Expense: 11544000000.00
PHI income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 11544000000.00
PHI income_statement (annual, 2022-12-31) — Interest Income: 653000000.00
PHI income_statement (annual, 2022-12-31) — Interest Income Non Operating: 653000000.00
PHI cash_flow (annual, 2022-12-31) — Interest Paid Cff: -9013000000.00
PHI balance_sheet (annual, 2022-12-31) — Interest Payable: 1868000000.00
PHI cash_flow (annual, 2022-12-31) — Interest Received Cfi: 636000000.00
PHI balance_sheet (annual, 2022-12-31) — Inventory: 3568000000.00
PHI balance_sheet (annual, 2022-12-31) — Invested Capital: 357797000000.00
PHI cash_flow (annual, 2022-12-31) — Investing Cash Flow: -33006000000.00
PHI balance_sheet (annual, 2022-12-31) — Investment Properties: 1015000000.00
PHI balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 4517000000.00
PHI balance_sheet (annual, 2022-12-31) — Investments And Advances: 56063000000.00
PHI balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 17922000000.00
PHI balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 33624000000.00
PHI cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 7839000000.00
PHI cash_flow (annual, 2022-12-31) — Issuance Of Debt: 21000000000.00
PHI balance_sheet (annual, 2022-12-31) — Land And Improvements: 46917000000.00
PHI balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 31958000000.00
PHI balance_sheet (annual, 2022-12-31) — Long Term Debt: 217288000000.00
PHI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 249246000000.00
PHI cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 5000000000.00
PHI cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -30684000000.00
PHI balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 51546000000.00
PHI balance_sheet (annual, 2022-12-31) — Long Term Provisions: 1514000000.00
PHI balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 665825000000.00
PHI balance_sheet (annual, 2022-12-31) — Minority Interest: 5234000000.00
PHI income_statement (annual, 2022-12-31) — Minority Interests: -250000000.00
PHI cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1056000000.00
PHI balance_sheet (annual, 2022-12-31) — Net Debt: 224369000000.00
PHI cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 4685000000.00
PHI income_statement (annual, 2022-12-31) — Net Income: 10485000000.00
PHI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 10426000000.00
PHI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 11335000000.00
PHI income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: -600000000.00
PHI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 10485000000.00
PHI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 11085000000.00
PHI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 13509000000.00
PHI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 10735000000.00
PHI cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
PHI income_statement (annual, 2022-12-31) — Net Interest Income: -11106000000.00
PHI cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 2332000000.00
PHI cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -15684000000.00
PHI cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -25684000000.00
PHI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -11106000000.00
PHI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -211000000.00
PHI cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -200000000.00
PHI balance_sheet (annual, 2022-12-31) — Net PPE: 321608000000.00
PHI cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -32970000000.00
PHI cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 7839000000.00
PHI cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 10000000000.00
PHI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 44178000000.00
PHI balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 662000000.00
PHI balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 316000000.00
PHI balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 17636000000.00
PHI balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 10132000000.00